List of MBioLIMS Customers
Marseille, 13009,
France
Since 2010, our global team of researchers has been studying MBioLIMS customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased MBioLIMS for Laboratory Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using MBioLIMS for Laboratory Management include: Institut Paoli-Calmettes France, a France based Healthcare organisation with 1700 employees and revenues of $240.0 million, Cryopal, a France based Manufacturing organisation with 86 employees and revenues of $25.0 million, Cryostem France, a France based Non Profit organisation with 15 employees and revenues of $1.0 million and many others.
Contact us if you need a completed and verified list of companies using MBioLIMS, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The MBioLIMS customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Cryopal | Manufacturing | 86 | $25M | France | Modul-Bio | MBioLIMS | Laboratory Management | 2023 | n/a |
In 2023, Cryopal implemented MBioLIMS as a hosted Laboratory Management solution from Modul-Bio to manage traceability of customer samples and daily operations for its outsourced cryogenic storage service in France. The implementation supports Cryopal within the BioKryo/Air Liquide biobanking network and centralizes chain of custody and inventory control for cryogenic samples.
MBioLIMS was configured to Cryopal's specific needs, with biorepository and outsourced biobank features enabled to support sample accessioning, inventory management, chain of custody, quality control logging, and operational reporting. Operational and quality teams use MBioLIMS for daily workflows and reporting, reflecting standard Laboratory Management functional workflows for biobanking operations.
The hosted deployment model removed the need for on premise infrastructure ownership and allowed Modul-Bio to deliver configuration and ongoing support, with rollout targeted at operational and quality functions across Cryopal sites in France. According to the vendor testimonial, the MBioLIMS deployment improved sample traceability and operational reporting for Cryopal's outsourced cryogenic storage service.
|
|
|
Cryostem France | Non Profit | 15 | $1M | France | Modul-Bio | MBioLIMS | Laboratory Management | 2012 | n/a |
In 2012 Cryostem France engaged MBioLIMS to deploy a multisite biobanking solution for the CRYOSTEM national GvHD cohort. The MBioLIMS deployment targeted multiple biological resource centers and transplant units across France and was developed and deployed within six months to support cohort operations and centralized sample management.
The implementation used MBioLIMS multi-site/cohort modules to standardize cohort and multisite biobanking processes, enabling cataloging and lifecycle tracking of aliquots, donor and sample metadata, and controlled access workflows. As a Laboratory Management application MBioLIMS provided core capabilities for sample accessioning, aliquot inventory management, and protocol-driven processing consistent with biobank operational requirements.
Operational coverage spanned participating BRCs and transplant units, consolidating sample records into a unified system to manage over 100,000 aliquots across sites. The architecture emphasized multisite data orchestration and consistent data models to support cross-site querying and cohort-level reporting.
Rollout governance emphasized standardized workflows and cohort governance to align site-level procedures, with a six month delivery timeline that enabled rapid adoption across the national cohort. The deployment enabled centralized management of sample inventories and cohort processes across Cryostem France sites, supporting ongoing operations of the CRYOSTEM GvHD study.
|
|
|
Institut Paoli-Calmettes France | Healthcare | 1700 | $240M | France | Modul-Bio | MBioLIMS | Laboratory Management | 2015 | n/a |
In 2015, Institut Paoli-Calmettes France implemented MBioLIMS to manage tumor bank and cell therapy product workflows at its comprehensive cancer centre in Marseille. The deployment centers on Laboratory Management functions for biobanking, with the application used to establish standardized sample traceability and operational handling across clinical and research sample flows.
The MBioLIMS implementation leverages tumor bank and BRC module usage to provide sample accessioning, inventory and storage management, chain of custody tracking, clinical annotation and cell therapy product tracking. Configuration covers specimen lifecycle management, quality control record capture and metadata management to support both operational staff and quality teams.
Operationally MBioLIMS is integrated into the institution’s IT fabric to improve interoperability with patient identifiers, scheduling data and laboratory workflow information, enabling daily operations for pathology, biobanking and cell therapy units. The integration focus supports data exchanges that maintain sample provenance and facilitate routine coordination between laboratory users and institutional systems.
Governance and process alignment concentrate on operational and quality team workflows, with MBioLIMS serving as the authoritative system for tumor bank traceability and cell therapy sample governance. The implementation improves interoperability with institutional IT and daily operations for operational and quality teams, strengthening end to end sample management and oversight.
|
Buyer Intent: Companies Evaluating MBioLIMS
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||